Forward to Quit: A Person-centered Mobile Technology Intervention for Smoking Cessation Among Transgender Adults
NCT ID: NCT07181551
Last Updated: 2025-09-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
44 participants
INTERVENTIONAL
2026-12-31
2031-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Project QUIT+: Adapting and Testing a Smoking Cessation Intervention for Transgender and Gender Expansive Individuals
NCT06654414
Advancing Smoking Cessation Among Transgender
NCT07099287
An Extended Facebook Intervention for Young Sexual and Gender Minority Smokers
NCT03553992
Tobacco Status Project: Social Media Intervention for Young Adult Smokers
NCT02207036
LGBT Internet Based Smoking Treatment - 1
NCT00111501
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
F2Q Intervention
Participants will receive access to the Forward to Quit (F2Q) mHealth smoking cessation intervention tailored for transgender adults
Forward to Quit (F2Q)
A mobile health (mHealth) smoking cessation intervention designed specifically for transgender adults. Delivered via a secure website accessible by smartphone or tablet.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Forward to Quit (F2Q)
A mobile health (mHealth) smoking cessation intervention designed specifically for transgender adults. Delivered via a secure website accessible by smartphone or tablet.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18+ years of age
* Report smoking at least 5 cigarettes per day
* Have smoked 100+ cigarettes in their lifetime
* Own a device that can access the Internet (e.g., tablet, smartphone)
* Speak English
* Be willing to submit biochemical samples to verify cessation
* Be willing to use a website-based intervention to help with quit attempt
* Be willing to set a quit date within 1 month of baseline assessment
* Be willing to complete 3 months post-baseline and 6 months post-baseline assessments
* Medical conditions precluding use of the carbon monoxide (CO) monitor or salivary cotinine testing
* Current use of pharmacotherapies for nicotine dependence
* Enrollment in another tobacco cessation program
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
University of Colorado, Denver
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christina Sun, PhD
Role: PRINCIPAL_INVESTIGATOR
Universtiy of Colorado Anschutz Medical Campus
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
22-2296
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.